• Improving early-stage drug discovery

    Supporting drug discovery teams in pharma, biotech and academic organisations, our boutique Discovery Services provide cutting-edge phenotypic insight to help shorten lead times and costs.

    • Fully collaborative services
    • Advanced discovery platform
    • Disease models with human relevance
    • Specialists in CNS and pain disease areas

Latest News

Free webinar: A humanized phenotypic screening platform for chronic pain

Thursday March 9th @ 4 pm CET (10 am EST) Don’t miss our upcoming webinar on stem cell-based pain and CNS […]

Cellectricon and Censo Biotechnologies introduce a joint technology access program utilizing high-quality Human iPSC-based discovery services for CNS and pain research

Mölndal, Sweden and Cambridge, UK – 26th January 2017 Cellectricon AB and Censo Biotechnologies Ltd are announcing the introduction of […]